Literature DB >> 15792730

Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia.

Mical Paul1, Leonard Leibovici.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15792730     DOI： 10.1016/S1473-3099(05)70030-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  11 in total

Review 1.  Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Authors:  Deepak Balasubramanian; Hansi Kumari; Kalai Mathee
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

Review 2.  Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.

Authors:  Mical Paul; Adi Lador; Simona Grozinsky-Glasberg; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-01-07

3.  Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms.

Authors:  J A Martínez; N Cobos-Trigueros; A Soriano; M Almela; M Ortega; F Marco; C Pitart; H Sterzik; J Lopez; J Mensa
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

Review 4.  Combination therapy for treatment of infections with gram-negative bacteria.

Authors:  Pranita D Tamma; Sara E Cosgrove; Lisa L Maragakis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

5.  Does the piperacillin minimum inhibitory concentration for Pseudomonas aeruginosa influence clinical outcomes of children with pseudomonal bacteremia?

Authors:  Pranita D Tamma; Alison E Turnbull; Aaron M Milstone; Alice J Hsu; Karen C Carroll; Sara E Cosgrove
Journal:  Clin Infect Dis       Date:  2012-06-13       Impact factor: 9.079

6.  Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.

Authors:  Laura Morata; Nazaret Cobos-Trigueros; José A Martínez; Alex Soriano; Manel Almela; Francesc Marco; Holguer Sterzik; Raquel Núñez; Cristina Hernández; José Mensa
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

7.  Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.

Authors:  Pranita D Tamma; Alison E Turnbull; Anthony D Harris; Aaron M Milstone; Alice J Hsu; Sara E Cosgrove
Journal:  JAMA Pediatr       Date:  2013-10       Impact factor: 16.193

8.  Outcomes of appropriate empiric combination versus monotherapy for Pseudomonas aeruginosa bacteremia.

Authors:  Dana R Bowers; Yi-Xin Liew; David C Lye; Andrea L Kwa; Li-Yang Hsu; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

9.  Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia.

Authors:  Ioannis A Bliziotis; Nicola Petrosillo; Argyris Michalopoulos; George Samonis; Matthew E Falagas
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

10.  A survey on infection management practices in Italian ICUs.

Authors:  Matteo Bassetti; Raffaele De Gaudio; Teresita Mazzei; Giulia Morace; Nicola Petrosillo; Pierluigi Viale; Giuseppe Bello; Sofia La Face; Massimo Antonelli
Journal:  Crit Care       Date:  2012-11-15       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.